Skip to content

Efficacy and Safety of Non-invasive Ventilation by Calibrated Leak in the Treatment of Respiratory Acidosis in ICU

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02630784
Acronym
VNI Versus
Enrollment
7
Registered
2015-12-15
Start date
2015-05-27
Completion date
2018-05-05
Last updated
2018-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Acidosis in ICU Patients

Keywords

Non-invasive ventilation, NIV ventilator, Exhalation by a calibrated leak, ICU ventilator, Respiratory acidosis, ICU

Brief summary

VNI Versus is a clinical, prospective, randomized, cross over study, aiming to compare two mechanical ventilators during non-invasive ventilation for patient suffering from respiratory acidosis. This study will compare a dedicated ventilator for Non Invasive Ventilation (NIV) functioning with a turbine and with vented mask (exhalation by a calibrated leak) and a dedicated ventilator for Intensive Care Unit (ICU), functioning with non-vented masks and an exhalation valve. Patient will be randomized before the first NIV session lasting 2 hours. After a two hours wash-out, a second NIV treatment will be delivered with the other ventilator for duration of 2 hours. Arterial blood samples will be collected at the beginning and the end of each session of NIV. A transcutaneous captor of dioxide carbon pressure (PCO2) will also be used for patient monitoring.

Interventions

PROCEDURENon-Invasive Ventilation with Homecare ventilator
PROCEDURENon-Invasive Ventilation with ICU ventilator

Sponsors

University Hospital, Grenoble
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Dioxide carbon arterial pressure \> 60 mmHg * Blood acidity (pH) \<7.36

Exclusion criteria

-Patient age under 18 * Pregnant woman * Cognitive disorder (other than the one induced by hypercapnia) * Acute intoxication with morphine or benzodiazepines * Patient already equipped prior to admission with a home NIV or Continuous Positive Airway Pressure (CPAP) device * All contraindications to NIV already described in the French Consensus Conference on NIV, from 2006.

Design outcomes

Primary

MeasureTime frameDescription
Carbon dioxide arterial pressure (PaCO2)After 2 hours of NIVAbsolute decrease in carbon dioxide arterial pressure (PaCO2) after 2 hours of ventilation

Secondary

MeasureTime frameDescription
Transcutaneous PCO26 hoursKinetic of the PaCO2 correction, monitored via transcutaneous PCO2 captor.
Börg dyspnea scale6 hours
Arterial blood acidity (pH) after 2 hours of NIVafter 2 hours of NIVCorrection of arterial blood acidity (pH) after 2 hours of NIV
Nurse satisfaction survey6 hours
Patient satisfaction survey6 hours
RASS score6 hours

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026